Allegiant Travel Company, a leisure travel company, provides travel and leisure services and products to residents of under-served cities in the United States.
FAIL · Does not pass the screen
91.97 USD
Price as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 16:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price91.97 USD at the 6 Nov 2026 close
Our value readFair vs our fair value, as of 6 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.51, read 2026-11-03
Ethical does not pass the values gate
Price91.97 USD
Fair value99.31
Ethical score70.0/100
Value readFairas of 6 Nov 2026
Our investment reviews on this name
2026-10-19Read Markdown70.40+30.6% to today Accumulation gives way to Markdown after a 10% slide in 4 weeks
2026-09-21Read Accumulation78.64+17.0% to today ✓Markdown gives way to Accumulation after a 7% slide in 4 weeks
2026-08-21Read Markdown84.44+8.9% to today Markup gives way to Markdown after an 8% slide in 7 weeks
2026-07-02Read Markup91.59+0.4% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Allegiant Travel Company holds its Markup at $91.97. Consolidating, no directional conviction, held for 3 days.
As held on the ledger · 2026-11-06
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 3 days
Price at the screen
$91.97
Valuation
69.68 trailing · 8.24 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.65
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
44.30%
Below 33%
Interest-bearing debt is 44.3% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
15.04%
Below 33%
Cash held in interest-bearing accounts and securities is 15.0% of assets, under the one-third limit.
Pass
Receivables
5.46%
Below 49%
Money owed to the company is 5.5% of assets, under the 49% limit.
Pass
Revenue purity
1.60%
Below 5%
Only 1.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Allegiant Travel's business is in a permissible area, but its interest-bearing debt is about 44% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ALGT's ethical verdict changes
Today ALGT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 6 Nov 2026: it trades at roughly a 7% discount to our $99.31 fair value, 36.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 7.4% discount to the base estimate.
Where our models see it going: fair-value estimate $99.31, with a range of $76.50 to $114.21, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cheap flights to small towns hide cyclical traps
Every time a family in a forgotten city books a weekend break, the plane still needs to cover fuel, staff and maintenance on routes that only run a few times a week. Allegiant built its model around those thin leisure flows, yet revenue is growing just 5 percent while the business posts a negative 1 percent profit margin and negative 3 percent return on equity.
The forward multiple of 8.2 times looks attractive next to analyst targets near 138 dollars, but this is exactly the setup that catches investors in cyclical airlines. Peak earnings can flatten fast when fuel spikes or demand for discretionary trips fades, turning a low multiple into a warning rather than a bargain. The ethical screen clears, yet the opportunity rating stays at none.
Margins already sit in the red and the industry moves with the economy, so any apparent margin of safety can vanish when cycles turn. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ALGT trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markdown$74.46+4.4%Entry 19
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markdown$71.34+0.0%Entry 18
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markdown$71.34+0.0%Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markdown$71.34-3.1%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markdown$73.59+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markdown$73.59+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markdown$73.59+5.1%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$70.05+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markdown$70.05-0.5%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100.
2026-10-19Markdown · changed$70.40-7.9%Entry 10
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (11 analysts) rates it buy, with a mean price target of $100.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
